PRODUCTS & SERVICES
This spring, CEWE decided to contribute to the fight against COVID-19 by launching a campaign where 1 cent would be donated for each photo, whether it was photos taken in CEWE laboratories or printed on CEWE photo stations in May and June 2020. By the end, a total of 6,583 euros was collected. With this donation, MultiplexDX will be able to provide Slovak laboratories with approximately one thousand RT-qPCR diagnostic tests for COVID-19.
Thank you, CEWE Slovakia team, and thanks to everyone who has contributed.
MultiplexDX is one of the most innovative biotech corporations, created to bring its revolutionary technologies to the market of personalized molecular diagnostics. The company has representation in both U.S. and European markets. The collaborators of MultiplexDX are from the world’s most prestigious scientific organizations including the National Cancer Institute, Rockefeller University, Albert Einstein University, Vanderbilt University, Cornell University, Queens University (Canada), Hebrew University of Jerusalem (Israel), and the Max Delbrück Center for Molecular Medicine (Germany).
MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining MDX proprietary visual and sequencing technologies into one diagnostic test. This cross-validation approach eliminates diagnostic errors and creates 100% precise cancer profiling for each patient which allows clinicians to suggest specific, personalized cancer treatment.